Leukemia Research
Volume 24, Issue 4 , Pages 299-305 , April 2000

Expression and phosphorylation status of retinoblastoma protein in adult T-cell leukemia/lymphoma

  • Katsushi Nakayama

      Affiliations

    • Department of Laboratory Medicine, Nagasaki University School of Medicine, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-95-8497420; fax: +81-95-8497422
    • ,
  • Yasuaki Yamada

      Affiliations

    • Department of Laboratory Medicine, Nagasaki University School of Medicine, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan
    • ,
  • Takehiko Koji

      Affiliations

    • Department of Histology and Cell Biology, Nagasaki University School of Medicine, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan
    • ,
  • Tomayoshi Hayashi

      Affiliations

    • Department of Pathology, Nagasaki University Hospital, Nagasaki, Japan
    • ,
  • Masao Tomonaga

      Affiliations

    • Department of Hematology, Molecular Medicine Unit, Atomic Disease Institute, Nagasaki University School of Medicine, Nagasaki, Japan
    • ,
  • Shimeru Kamihira

      Affiliations

    • Department of Laboratory Medicine, Nagasaki University School of Medicine, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan

Received 16 June 1999 ,Accepted 2 October 1999.

References 

  1. Shimoyama M, Ota K, Kikuci M, Yunoki K, Konda S, Takatsuki K, Ichimaru M, Tominaga S, Tsugane S, Minato K, Tobinai K, Oyama A, Hisano S, Matsumoto M, Takiguchi T, Yamaguchi K, Kinoshita K, Tajima K, Suemasu K. [For the Lymphoma Study Group (1981–1983)], Major prognostic factors of adult patients with advanced T cell lymphoma/leukemia, J Clin Oncol 1988;6:1088.
  2. Murphree AL, Benedict WF. Retinoblastoma: clues to human oncogenesis. Science. 1984;223:1028
  3. Lee WH, Bookstein R, Hong F, Young L, Shew J, Lee EYHP. Human retinooblastoma susceptibility gene: cloning, identification, and sequence. Science. 1987;235:1394
  4. Xu HJ, Hu SX, Hashimoto T, Takahashi R, Benedict WF. The retinoblastoma susceptibility gene product: a characteristic pattern in normal cells and abnormal expression in malignant cells. Oncogene. 1989;4:807
  5. Goodrich D, Lee WH. Molecular characterization of the retinoblastoma susceptibility gene. Biochim. Biophys. Acta. 1993;1155:31
  6. McFall R, Sery T, Makadon M. Characterization of a new continuous cell line derived from a human retinoblastoma. Cancer Res. 1977;37:1003
  7. Harbour J, Lai S, Whang P, Gazdar A, Minna J, Kaye F. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science. 1988;241:353
  8. Cairns P, Proctor A, Knowles M. Loss of heterozygosity at the RB locus is frequent and correlates with muscle inavation in bladder carcinoma. Oncogene. 1991;6:2305
  9. Jamal R, Gale RE, Thomas NSB, Wheatley K, Lynch DC. The retinoblastoma gene (rb1) in acute myeloid leukaemia: analysis of gene rearrangements, protein expression and comparison of disease outcome. Br. J. Haematol. 1996;94:342
  10. Kornblau SM, Chen N, del Giglio A, O’Brien S, Deisseroth AB. Retinoblastoma protein expression is frequently altered in chronic lymphocytic leukemia. Cancer Res. 1994;54:242
  11. Towatari M, Adachi K, Kato H, Saito H. Absence of the human retinoblastoma gene product in the megakaryoblastic crisis of chronic myelogenous leukemia. Blood. 1991;78:2178
  12. Weide R, Tiemann M, Pfluger K, et al.  Altered expression of the retinoblastoma gene product in human high-grade non-Hodgkin’s lymphomas. Leukemia. 1994;12:97
  13. Hangaishi A, Ogawa S, Imamura N, et al.  Inactivation of multiple tumor suppressor genes involved in negative regulation of the cell cycle, MTS1/p16INK4A/CDKN2, MTS2/pINK4B, p53, and Rb genes in primary lymphoid malignancies. Blood. 1996;87:4949
  14. Hatta Y, Yamada Y, Tomonaga M, Koeffler HP. Extensive analysis of the retinoblastoma gene in adult T cell leukemia/lymphoma (ATL). Leukemia. 1997;11:984
  15. Yamada Y, Fujita M, Suzuki H, et al.  Established IL-2-dependent double-negative (CD4- CD8-) TCRap/CD3+ ATL cells: induction of CD4 expression. Br. J. Haematol. 1994;88:234
  16. Yamada Y, Nagata Y, Kamihira S, et al.  IL-2 dependent ATL cell lines with phenotypes differing from the original leukemia cells. Leuk. Res. 1991;7:619
  17. Shimoyama M, Members of the Lymphoma Study Group. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia/lymphoma, Br J Haematol 1991;79:428.
  18. Lee WH, Shew JY, Hong FD, et al.  The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature. 1987;329:642
  19. Shew JY, Lin BT, Chen PL, Tseng BY, Yang FT, Lee WH. Terminal truncation of the retinoblastoma gene product leads to functional inactivation. Proc. Natl. Acad. Sci. USA. 1990;87:6
  20. Bookstein R, Lee EYHP, To H, et al.  Human retinoblastoma susceptibility gene: genomic organization and analysis of heterozygous intragenic deletion mutants. Proc. Natl. Acad. Sci. USA. 1988;85:2210
  21. Stirzaker C, Millar DS, Paul CL, et al.  Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors. Cancer Res. 1997;57:2229
  22. Chen PL, Scully P, Shew JY, Wang JY, Lee WH. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell. 1989;58:1193
  23. DeCaprio JA, Ludlow JW, Lynch D, et al.  The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell. 1989;58:1085
  24. Kornblau SM, Xu HJ, del Giglio A, et al.  Clinical implications of decreased retinoblastoma protein expression in acute myelogenous leukemia. Cancer Res. 1992;52:4587
  25. Furukawa Y, DeCaprio JA, Freedmann A, et al.  Expression and state of phosphorylation of the retinoblastoma susceptibility gene product in cycling and noncycling human hematopoietic cells. Proc. Natl. Acad. Sci. USA. 1990;87:2770
  26. Tsai T, Davalath S, Rankin C, Radich JP, Head D, Appelbaum FR, et al. Tumor suppressor gene alteration in adult acute lymphoblastic leukemia (AL,L). Analysis of retinoblastoma (Rb) and p53 gene expression in lymphoblasts of patients with de novo, relapsed, or refractory ALL treated in Southwest Oncology Group studies. Leukemia. 1996;10:1901
  27. Zhang X, Xu HJ, Murakami Y, et al.  Deletions of chromosome 13q mutations in retinoblastoma 1 and retinoblastoma protein state in human hepatocellular carcinomas. Cancer Res. 1994;54:4177
  28. Martinez JC, Piris MA, Sanchez-Beato M, et al.  Retinoblastoma (Rb) gene product expression in lymphomas: correlation with Ki67 growth fraction. J. Pathol. 1993;169:405
  29. Martinez JC, Piris MA, Sanchez-Beato M, et al.  Retinoblastoma (Rb) gene product expression in lymphomas: correlation with Ki67 growth fraction. J. Pathol. 1993;169:405
  30. Grossman HB, Liebert M, Antelo M, Dinney CPN, Hu SX, Palmer JL, et al. p53 and RB expression predict progression in T1 bladder cancer. Clin. Cancer Res. 1998;4:829
  31. Cote RJ, Dunn MD, Chatterjee SJ, et al.  Elevated and absent pRb expression is associated with bladder cancer progression, and has cooperative effects with pS3. Cancer Res. 1998;58:1090
  32. Dunn MD, Stein JP, Shi SR, et al.  Retinoblastoma protein in bladder cancer: level of expression correlates with tumor progression. J. Urol. 1997;157:341A
  33. Haas-Kogan DA, Kogan SC, Levi D, Dazin P, T'Ang A, Fung Y-KT, et al. Inhibition of apoptosis by the retinoblastoma gene product. EMBO J. 1997;14:461

PII: S0145-2126(99)00186-1

Leukemia Research
Volume 24, Issue 4 , Pages 299-305 , April 2000

Article Tools

* Image Usage & Resolution